320 related articles for article (PubMed ID: 28295226)
1. Lacosamide in status epilepticus: Systematic review of current evidence.
Strzelczyk A; Zöllner JP; Willems LM; Jost J; Paule E; Schubert-Bast S; Rosenow F; Bauer S
Epilepsia; 2017 Jun; 58(6):933-950. PubMed ID: 28295226
[TBL] [Abstract][Full Text] [Related]
2. Intravenous Lacosamide in refractory nonconvulsive status epilepticus.
Mnatsakanyan L; Chung JM; Tsimerinov EI; Eliashiv DS
Seizure; 2012 Apr; 21(3):198-201. PubMed ID: 22244046
[TBL] [Abstract][Full Text] [Related]
3. Intravenous lacosamide in clinical practice-Results from an independent registry.
Lang N; Lange M; Schmitt FC; Bös M; Weber Y; Evers S; Burghaus L; Kellinghaus C; Schubert-Bast S; Bösel J; Lammers T; Sabolek M; van Baalen A; Dziewas R; Kraft A; Ruf S; Stephani U
Seizure; 2016 Jul; 39():5-9. PubMed ID: 27161669
[TBL] [Abstract][Full Text] [Related]
4. Intravenous lacosamide in status epilepticus and seizure clusters.
Höfler J; Unterberger I; Dobesberger J; Kuchukhidze G; Walser G; Trinka E
Epilepsia; 2011 Oct; 52(10):e148-52. PubMed ID: 21801171
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of lacosamide in children and adolescents with drug-resistant epilepsy and refractory status epilepticus: A systematic review.
Ortiz de la Rosa JS; Ladino LD; Rodríguez PJ; Rueda MC; Polanía JP; Castañeda AC
Seizure; 2018 Mar; 56():34-40. PubMed ID: 29428899
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study.
Sutter R; Marsch S; Rüegg S
CNS Drugs; 2013 Apr; 27(4):321-9. PubMed ID: 23533010
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of lacosamide and phenytoin in status epilepticus: A systematic review.
Panda PK; Panda P; Dawman L; Sharawat IK
Acta Neurol Scand; 2021 Oct; 144(4):366-374. PubMed ID: 33999428
[TBL] [Abstract][Full Text] [Related]
8. The Safety and Effectiveness of Intravenous Lacosamide for Refractory Status Epilepticus in the Critically Ill.
Newey CR; Le NM; Ahrens C; Sahota P; Hantus S
Neurocrit Care; 2017 Apr; 26(2):273-279. PubMed ID: 27844464
[TBL] [Abstract][Full Text] [Related]
9. Lacosamide in children with refractory status epilepticus. A multicenter Italian experience.
Grosso S; Zamponi N; Bartocci A; Cesaroni E; Cappanera S; Di Bartolo R; Balestri P
Eur J Paediatr Neurol; 2014 Sep; 18(5):604-8. PubMed ID: 24836405
[TBL] [Abstract][Full Text] [Related]
10. Comparison of lacosamide versus sodium valproate in status epilepticus: A pilot study.
Misra UK; Dubey D; Kalita J
Epilepsy Behav; 2017 Nov; 76():110-113. PubMed ID: 28919386
[TBL] [Abstract][Full Text] [Related]
11. Intravenous lacosamide in seizure emergencies: Observations from a hospitalized in-patient adult population.
d'Orsi G; Pascarella MG; Martino T; Carapelle E; Pacillo F; Di Claudio MT; Mancini D; Trivisano M; Avolio C; Specchio LM
Seizure; 2016 Nov; 42():20-28. PubMed ID: 27693808
[TBL] [Abstract][Full Text] [Related]
12. Intravenous lacosamide (LCM) in status epilepticus (SE): Weight-adjusted dose and efficacy.
Santamarina E; González-Cuevas M; Toledo M; Jiménez M; Becerra JL; Quílez A; Suller A; Mauri JA; Fernández Á; Marinas A; Quintana M; Puig XS
Epilepsy Behav; 2018 Jul; 84():93-98. PubMed ID: 29758445
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of intravenous lacosamide in status epilepticus.
Santamarina E; Toledo M; Sueiras M; Raspall M; Ailouti N; Lainez E; Porta I; De Gracia R; Quintana M; Alvarez-Sabín J; Xavier Salas Puig XS
J Neurol; 2013 Dec; 260(12):3122-8. PubMed ID: 24122063
[TBL] [Abstract][Full Text] [Related]
14. Intravenous lacosamide in refractory seizure clusters and status epilepticus: comparison of 200 and 400 mg loading doses.
Legros B; Depondt C; Levy-Nogueira M; Ligot N; Mavroudakis N; Naeije G; Gaspard N
Neurocrit Care; 2014 Jun; 20(3):484-8. PubMed ID: 23896816
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study.
Garcés M; Villanueva V; Mauri JA; Suller A; García C; López González FJ; Rodríguez Osorio X; Fernández Pajarín G; Piera A; Guillamón E; Santafé C; Castillo A; Giner P; Torres N; Escalza I; Del Villar A; García de Casasola MC; Bonet M; Noé E; Olmedilla N
Epilepsy Behav; 2014 Jul; 36():144-52. PubMed ID: 24922617
[TBL] [Abstract][Full Text] [Related]
16. Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.
Kellinghaus C; Berning S; Stögbauer F
Acta Neurol Scand; 2014 May; 129(5):294-9. PubMed ID: 23937330
[TBL] [Abstract][Full Text] [Related]
17. Observational study of intravenous lacosamide in patients with convulsive versus non-convulsive status epilepticus.
Moreno Morales EY; Fernandez Peleteiro M; Bondy Peña EC; Domínguez Lorenzo JM; Pardellas Santiago E; Fernández A
Clin Drug Investig; 2015 Jul; 35(7):463-9. PubMed ID: 26108190
[TBL] [Abstract][Full Text] [Related]
18. Intravenous Lacosamide in Pediatric Status Epilepticus: An Open-Label Efficacy and Safety Study.
Poddar K; Sharma R; Ng YT
Pediatr Neurol; 2016 Aug; 61():83-6. PubMed ID: 27241232
[TBL] [Abstract][Full Text] [Related]
19. Lacosamide treatment of childhood refractory focal epilepsy: the first reported side effect in paediatric patients.
Yildiz EP; Ozkan MU; Bektas G; Uzunhan TA; Aydinli N; Caliskan M; Ozmen M
Childs Nerv Syst; 2017 Nov; 33(11):2023-2027. PubMed ID: 28884208
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of intravenous lacosamide in refractory nonconvulsive status epilepticus and simple partial status epilepticus.
Rantsch K; Walter U; Wittstock M; Benecke R; Rösche J
Seizure; 2011 Sep; 20(7):529-32. PubMed ID: 21489827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
